Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum

Nature Neuroscience

Volumn 11, Issue 2, 2008, Pages 152-159

  Maccarrone, Mauro ^a,b   Rossi, Silvia ^b,c   Bari, Monica ^d   De Chiara, Valentina ^b,c   Fezza, Filomena ^b,d   Musella, Alessandra ^b,c   Gasperi, Valeria ^a   Prosperetti, Chiara ^b,c   Bernardi, Giorgio ^b,c   Finazzi Agrò, Alessandro ^d   Cravatt, Benjamin F ^e   Centonze, Diego ^b,c  

^a UNIVERSITY OF TERAMO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 3,5 DIHYDROXYPHENYLGLYCINE; 4 AMINOBUTYRIC ACID; ANANDAMIDE; CANNABINOID 1 RECEPTOR; FATTY ACID AMIDASE; GLUTATHIONE; METABOTROPIC RECEPTOR 5; METHANANDAMIDE; VANILLOID RECEPTOR 1;

ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN SLICE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; DOWN REGULATION; MOUSE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; STIMULATION; SYNAPTIC TRANSMISSION; UPREGULATION;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; CORPUS STRIATUM; DOWN-REGULATION; DRUG INTERACTIONS; ENDOCANNABINOIDS; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTATHIONE; GLYCERIDES; METHOXYHYDROXYPHENYLGLYCOL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PATCH-CLAMP TECHNIQUES; POLYUNSATURATED ALKAMIDES; PROTEIN BINDING; RECEPTOR, CANNABINOID, CB1; SYNAPTIC TRANSMISSION; TIME FACTORS; TRPV CATION CHANNELS;

EID: 38649097877     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn2042     Document Type: Article

References (50)

1. Piomelli, D. The molecular logic of endocannabinoid signaling. Nat. Rev. Neurosci. 4, 873-884 (2003).
2. Chevaleyre, V., Takahashi, K.A. & Castello, P.E. Endocannabinoid- mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29, 37-76 (2006).
3. Freund, T.F., Katona, I. & Piomelli, D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017-1066 (2003).
4. Barinaga, M. How cannabinoids work in the brain. Science 291, 2530-2531 (2001).
5. Kreitzer, A.C. & Regehr, W.G. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29, 717-727 (2001).
6. Wilson, R.I. & Nicoll, R.A. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410, 588-592 (2001).
7. Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A. & Kano, M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31, 463-475 (2001).
8. Melis, M. et al. Prefrontal cortex stimulation induces 2-arachidonoyl glycerol-mediated suppression of excitation in dopamine neurons. J. Neurosci. 24, 10707-10715 (2004).
9. Gerdeman, G.L., Ronesi, J. & Lovinger, D.M. Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nat. Neurosci. 5, 446-451 (2002).
10. Uchigashima, M. et al. Subcellular arrangement of molecules for 2-arachidonoyl glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J. Neurosci. 27, 3663-3676 (2007).
11. Soler-Llavina, G.J. & Sabatini, B.L. Synapse-specific plasticity and compartmentalized signaling in cerebellar stellate cells. Nat. Neurosci. 9, 798-806 (2006).
12. Ohno-Shosaku, T., Shosaku, J., Tsubokawa, H. & Kano, M. Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. Eur. J. Neurosci. 15, 953-961 (2002).
13. Rouach, N. & Nicoll, R.A. Endocannabinoids contribute to short-term, but not long-term, mGluR-induced depression in the hippocampus. Eur. J. Neurosci. 18, 1017-1020 (2003).
14. 2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse. J. Neurosci. 24, 5955-5965 (2004).
15. Kreitzer, A.C. & Malenka, R.C. Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. J. Neurosci. 25, 10537-10545 (2005).
16. Centonze, D. et al. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biol. Psychiatry 57, 1583-1589 (2005).
17. Sarnataro, D. et al. Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. FEBS Lett. 579, 6343-6349 (2005).
18. Bisogno, T. et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid knockout in the brain. J. Cell Biol. 163, 463-468 (2003).
19. Dinh, T.P. et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. USA 99, 10819-10824 (2002).
20. Hermann, A., Kaczocha, M. & Deutsch, D.G. 2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook. AAPS J. 8, E409-412 (2006).
21. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T. & Ueda, N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279, 5298-5305 (2004).
22. Glaser, S.T., Kaczocha, M. & Deutsch, D.G. Anandamide transport: a critical review. Life Sci. 77, 1584-1604 (2005).
23. Bari, M., Battista, N., Fezza, F., Gasperi, V. & Maccarrone, M. New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev. Med. Chem. 6, 275-268 (2006).
24. McKinney, M.K. & Cravatt, B.F. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 74, 411-432 (2005).
25. Bisogno, T. et al. Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. Biochim. Biophys. Acta 1761, 205-212 (2006).
26. Kathuria, S. et al. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9, 76-81 (2003).
27. Cravatt, B.F. et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signalling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA 98, 9371-9376 (2001).
28. Starowicz, K., Nigam, S. & Di Marzo, V. Biochemistry and pharmacology of endovanilloids. Pharmacol. Ther. 114, 13-33 (2007).
29. Cristino, L. et al. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139, 1405-1415 (2006).
30. Evans, R.M., Scott, R.H. & Ross, R.A. Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br. J. Pharmacol. 141, 1223-1233 (2004).
31. Sagara, Y. & Schubert, D. The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J. Neurosci. 18, 6662-6671 (1998).
32. Jhaveri, M.D., Richardson, D., Kendall, D.A., Barrett, D.A. & Chapman, V. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain. J. Neurosci. 26, 13318-13327 (2006).
33. Maione, S. et al. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. J. Pharmacol. Exp. Ther. 316, 969-982 (2006).
34. de Lago, E. et al. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels. Biochem. Pharmacol. 70, 446-452 (2005).
35. Kim, J. & Alger, B.E. Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci. 7, 697-698 (2004).
36. Makara, J.K. et al. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. Nat. Neurosci. 8, 1139-1141 (2005).
37. Melis, M. et al. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiol. Dis. 24, 15-27 (2006).
38. Szabo, B. et al. Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J. Physiol. (Lond.) 577, 263-280 (2006).
39. Valenti, M. et al. Differential diurnal variations of anandamide and 2-arachidonoylglycerol levels in rat brain. Cell. Mol. Life Sci. 61, 945-950 (2004).
40. Sugiura, T., Kobayashi, Y., Oka, S. & Waku, K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids 66, 173-192 (2002).
41. Bisogno, T. et al. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun. 256, 377-380 (1999).
42. Di Marzo, V., Hill, M.P., Bisogno, T., Crossman, A.R. & Brotchie, J.M. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. FASEB J. 14, 1432-1438 (2000).
43. Guo, Y. et al. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J. Biol. Chem. 280, 23429-23432 (2005).
44. Jung, K.M. et al. Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. Mol. Pharmacol. 68, 1196-1202 (2005).
45. Gubellini, P. et al. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J. Neurosci. 22, 6900-6907 (2002).
46. Pisani, A., Bonsi, P., Centonze, D., Bernardi, G. & Calabresi, P. Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons. Neuropharmacology 40, 460-463 (2001).
47. Pellmar, T.C., Roney, D. & Lepinski, D.L. Role of glutathione in repair of free radical damage in hippocampus in vitro. Brain Res. 583, 194-200 (1992).
48. Cartoni, A., Margonelli, A., Angelini, G., Finazzi Agrò, A. & Maccarrone, M. Simplified chemical and radiochemical synthesis of 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Tetrahedr. Lett. 45, 2723-2726 (2004).
49. Fezza, F., Gasperi, V., Mazzei, C. & Maccarrone, M. Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPE-PLD) activity. Anal. Biochem. 339, 113-120 (2005).
50. Wang, Y. et al. Simultaneous measurement of anandamide and 2-arachidonoylglycerol by polymixin B-selective adsorption and subsequent high-performance liquid chromatography analysis: increase in endogenous cannabinoids in the sera of patients with endotoxic shock. Anal. Biochem. 294, 73-82 (2001).